Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8739738 | Journal of Clinical Virology | 2018 | 37 Pages |
Abstract
The effectiveness of Maraviroc as a component in salvage therapy may be compromised for a significant number of chronically infected patients harboring CXCR4 utilizing viruses.
Related Topics
Life Sciences
Immunology and Microbiology
Applied Microbiology and Biotechnology
Authors
Nontokozo D. Matume, Denis M. Tebit, Laurie R. Gray, Marie-Louise Hammarskjold, David Rekosh, Pascal O. Bessong,